Articles, App Notes, Case Studies, & White Papers

31. Overcoming Melt Processing Challenges 7/21/2023

    Discover how a biodegradable polymer platform, easily applied with hot melt processing, enables processing at a relatively low temperature while preserving the potency of temperature-sensitive APIs.

32. 3 Keys To Rare Disease Clinical, Commercial Drug Product Manufacturing 1/14/2022

    The complex biology of rare diseases creates unique hurdles, making it difficult to design and implement a drug development program. Explore the unique considerations for drug product manufacturing.

33. Small Is Powerful And Sustained

    Advances in sustained-release drug delivery could improve efficiency and consistency in drug release, manifesting real-life advantages for patients in the form of enhanced accessibility and compliance.

34. 4 Factors Affecting Solubility Of Drugs 2/28/2022

    Improper drug solubility can lead to suboptimal drug delivery and absorption, resulting in ineffective drug efficacy and side effects, so solubility must be evaluated in the early stages of drug discovery.

35. Fixtures And Surrogates For Combination Product Performance Testing 5/16/2025

    The combination product market is consistently expanding. Transitioning from traditional vial systems to needle-based combination products presents several challenges that require careful consideration.

36. Stability Chambers: Testing, Equipment, And Uses 3/7/2023

    Performing stability studies is a critical step in the drug development process. Discover the ways to ensure that your drug is safe and effective as it goes to market.

37. How Approved Drugs Have Evolved Since The '70s

    Drugs have become more lipophilic and complex in structure over time. Innovative strategies are needed to improve the bioavailability of these new drugs.

38. Nanoformed API: A Superior Alternative To Solid Dispersions 7/29/2024

    Cutting-edge nanotechnology is now emerging, able to address bioavailability challenges and deliver higher drug loads in more patient-friendly formats with fewer and smaller pills and easier regimens.

39. Insights Into Drug Delivery Device Manufacturing From Development Through Commercialization 4/5/2018

    Biologics and other targeted therapy techniques are creating opportunities for innovative device solutions that meet the needs of specific patient groups. As these therapies often require low annual volumes, the associated device manufacturing strategy must also fit commercial expectations, even at those volumes. 

40. Solid Form Strategies For Increasing Oral Bioavailability

    Optimizing a drug’s solid form can improve its solubility and bioavailability when further molecular modifications are prohibitive.